相似文献
1
Trafficking of immune cells in the central nervous system.
J Clin Invest. 2010 May;120(5):1368-79. doi: 10.1172/JCI41911. Epub 2010 May 3.
2
The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
Curr Pharm Des. 2008;14(16):1555-65. doi: 10.2174/138161208784705432.
3
Immune regulation within the central nervous system.
J Neurol Sci. 1998 Apr 15;157(1):1-12. doi: 10.1016/s0022-510x(98)00049-5.
4
The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms.
Trends Immunol. 2005 Sep;26(9):485-95. doi: 10.1016/j.it.2005.07.004.
5
Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.
Immunol Rev. 2006 Oct;213:195-212. doi: 10.1111/j.1600-065X.2006.00433.x.
6
Regulation of immune cell entry into the central nervous system.
Results Probl Cell Differ. 2006;43:259-80. doi: 10.1007/400_020.
7
Analysis of leukocyte extravasation across the blood-brain barrier: conceptual and technical aspects.
Curr Allergy Asthma Rep. 2004 Jan;4(1):65-73. doi: 10.1007/s11882-004-0046-9.
8
Inflammatory cell migration into the central nervous system: a few new twists on an old tale.
Brain Pathol. 2007 Apr;17(2):243-50. doi: 10.1111/j.1750-3639.2007.00067.x.
9
Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details.
Curr Opin Immunol. 2006 Dec;18(6):683-9. doi: 10.1016/j.coi.2006.09.005. Epub 2006 Sep 28.
10
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Trends Immunol. 2012 Dec;33(12):579-89. doi: 10.1016/j.it.2012.07.004. Epub 2012 Aug 25.
引用本文的文献
1
Neutrophils-astrocyte interactions in central nervous system inflammation.
Cell Death Dis. 2025 Aug 25;16(1):643. doi: 10.1038/s41419-025-07945-x.
2
Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma.
Sci Rep. 2025 Jul 17;15(1):25981. doi: 10.1038/s41598-025-10107-w.
3
Resolving Inflammation: The Impact of Antiretroviral Therapy on Macrophage Traffic In and Out of the CNS.
bioRxiv. 2025 May 8:2025.05.02.651872. doi: 10.1101/2025.05.02.651872.
4
Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research.
Mol Psychiatry. 2025 Jul 3. doi: 10.1038/s41380-025-03085-y.
5
Multiple sclerosis: etiology in the context of neurovascular unit and immune system involvement and advancements with blood-brain barrier models.
Front Immunol. 2025 Jun 10;16:1595276. doi: 10.3389/fimmu.2025.1595276. eCollection 2025.
6
The Diagnosis of Sepsis-Associated Encephalopathy Using Biomarkers: Are We There Yet?
Avicenna J Med. 2025 May 6;15(2):51-63. doi: 10.1055/s-0045-1808060. eCollection 2025 Apr.
7
Tumor Microenvironment in Melanoma Brain Metastasis: A New Potential Target?
Int J Mol Sci. 2025 May 23;26(11):5018. doi: 10.3390/ijms26115018.
8
The integrated stress response in neurodegenerative diseases.
Mol Neurodegener. 2025 Feb 19;20(1):20. doi: 10.1186/s13024-025-00811-6.
9
β2 integrin regulates neutrophil trans endothelial migration following traumatic brain injury.
Cell Commun Signal. 2025 Feb 8;23(1):70. doi: 10.1186/s12964-025-02071-9.
10
Inflammatory changes in the choroid plexus following subarachnoid hemorrhage: the role of innate immune receptors and inflammatory molecules.
Front Cell Neurosci. 2025 Jan 7;18:1525415. doi: 10.3389/fncel.2024.1525415. eCollection 2024.
本文引用的文献
1
Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria.
J Immunol. 2009 Dec 1;183(11):7014-22. doi: 10.4049/jimmunol.0901422. Epub 2009 Nov 4.
2
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Nature. 2009 Nov 5;462(7269):94-8. doi: 10.1038/nature08478. Epub 2009 Oct 14.
3
Reemergence of PML in natalizumab-treated patients--new cases, same concerns.
N Engl J Med. 2009 Sep 10;361(11):1041-3. doi: 10.1056/NEJMp0906248.
4
Therapy: Targeted but not trouble-free: efalizumab and PML.
Nat Rev Rheumatol. 2009 Aug;5(8):418-9. doi: 10.1038/nrrheum.2009.142.
5
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.
Curr Neuropharmacol. 2008 Sep;6(3):179-92. doi: 10.2174/157015908785777210.
6
CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Eur J Immunol. 2009 Jun;39(6):1671-81. doi: 10.1002/eji.200839123.
7
Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii.
J Immunol. 2009 May 15;182(10):6379-93. doi: 10.4049/jimmunol.0804307.
8
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.
Nat Immunol. 2009 May;10(5):514-23. doi: 10.1038/ni.1716. Epub 2009 Mar 22.
9
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis.
Ann Neurol. 2009 Feb;65(2):230; author reply 230-31. doi: 10.1002/ana.21547.
10
Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.
J Immunol. 2009 Mar 1;182(5):3121-30. doi: 10.4049/jimmunol.0713169.
Zotero 插件